Literature DB >> 21992819

Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition.

Anna-Karin Boström1, Christina Möller, Elise Nilsson, Peter Elfving, Håkan Axelson, Martin E Johansson.   

Abstract

Approximately 8% of clear cell renal cell carcinoma cases contain regions of radically different morphology, demonstrating a mesenchymal appearance histologically resembling sarcomas. These biphasic neoplasms are called sarcomatoid clear cell renal cell carcinoma. Patients diagnosed with sarcomatoid clear cell renal cell carcinoma face a considerably worse prognosis due to an increased propensity for metastasis. In the present study we investigate whether the sarcomatoid conversion of clear cell renal cell carcinoma could be interpreted as linked to the process of epithelial-mesenchymal transition. Using 6 biphasic clear cell renal cell carcinoma cases we show that sarcomatoid clear cell renal cell carcinoma shares characteristic markers associated with loss of von Hippel-Lindau tumor suppressor with conventional clear cell renal cell carcinoma and also exhibits a markedly higher proliferative index. Furthermore the sarcomatoid elements demonstrate an enhanced expression of epithelial-mesenchymal transition related mesenchymal markers as compared with the clear cell renal cell carcinoma counterparts. We further selected a representative case, clinically demonstrating direct overgrowth of the sarcomatoid component into the liver and colon, for extended immunohistochemical characterization, resulting in a further set of positive and negative epithelial-mesenchymal transition markers as well as pronounced transforming growth factor β positivity, indicating that sarcomatoid clear cell renal cell carcinoma may be associated to epithelial-mesenchymal transition. Transforming growth factor β1 exposure of in vitro cultured primary clear cell renal cell carcinoma cells resulted in cells adopting a mesenchymal morphology similar to sarcomatoid clear cell renal cell carcinoma. Corresponding changes in RNA levels for key epithelial-mesenchymal transition markers were also seen. We therefore suggest that sarcomatoid clear cell renal cell carcinoma morphologically and immunohistochemically may represent a completed epithelial-mesenchymal transition and that transforming growth factor β1 could be an important driving force during the sarcomatoid transdifferentiation of clear cell renal cell carcinoma.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21992819     DOI: 10.1016/j.humpath.2011.06.019

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  20 in total

1.  Unusual early-stage pancreatic sarcomatoid carcinoma.

Authors:  Chuan-Li Ren; Ping Jin; Chong-Xu Han; Qin Xiao; Dao-Rong Wang; Lin Shi; Da-Xin Wang; Hui Chen
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

2.  The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.

Authors:  Yan Qi; Cui-Cui Wang; Yong-Lai He; Hong Zou; Chun-Xia Liu; Li-Juan Pang; Jian-Ming Hu; Jin-Fang Jiang; Wen-Jie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

3.  Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.

Authors:  Okyaz Eminaga; Ilgar Akbarov; Sebastian Wille; Udo Engelmann
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

4.  Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.

Authors:  Daniel P Nguyen; Antoni Vilaseca; Emily A Vertosick; Renato B Corradi; Karim A Touijer; Nicole E Benfante; Daniel D Sjoberg; Paul Russo
Journal:  World J Urol       Date:  2015-07-28       Impact factor: 4.226

5.  Stability of preclinical models of aggressive renal cell carcinomas.

Authors:  Mariana Varna; Guilhem Bousquet; Irmine Ferreira; Marie Goulard; Morad El-Bouchtaoui; Pierre Mongiat Artus; Jérome Verine; Eric de Kerviler; Lucie Hernandez; Christophe Leboeuf; Bernard Escudier; Luc Legrès; Niclas Setterblad; Hany Soliman; Jean-Paul Feugeas; Anne Janin; Philippe Bertheau
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 6.  Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.

Authors:  Francesco Piva; Matteo Giulietti; Matteo Santoni; Giulia Occhipinti; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Giovanni Principato; Rodolfo Montironi
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

Review 7.  Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors.

Authors:  Annika Jögi; Marica Vaapil; Martin Johansson; Sven Påhlman
Journal:  Ups J Med Sci       Date:  2012-02-29       Impact factor: 2.384

8.  Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression.

Authors:  Hosny M Behnsawy; Katsumi Shigemura; Fatma Y Meligy; Fukashi Yamamichi; Masuo Yamashita; Wen-Chin Haung; Xiangyan Li; Hideaki Miyake; Kazushi Tanaka; Masato Kawabata; Toshiro Shirakawa; Masato Fujisawa
Journal:  Korean J Urol       Date:  2013-08-07

9.  Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate.

Authors:  H Nilsson; D Lindgren; A Mandahl Forsberg; H Mulder; H Axelson; M E Johansson
Journal:  Cell Death Dis       Date:  2015-01-08       Impact factor: 8.469

Review 10.  Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma.

Authors:  Prashanth Prithviraj; Nuzhat Ahmed; Revati Sharma; Elif Kadife; Mark Myers; George Kannourakis
Journal:  J Exp Clin Cancer Res       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.